Advances in molecular studies have subdivided hepatocellular adenoma into 4 different types: HNF1[alpha] inactivated, [beta]-catenin activated, inflammatory, and unclassified.
Distinction Between Inflammatory Hepatocellular Adenoma and FNH
The optimal relative potencies for cholangiocarcinoma and hepatocellular adenoma were 0.
In contrast, the models for hepatocellular adenoma and gingival SCC were not rejected (Table 2, WHO model; p > 0.
Focal nodular hyperplasia and hepatocellular adenoma
around the world viewed through the scope of the immunopathological classification.
Overview of hepatocellular adenoma in Japan [published online ahead of print September 2, 2012].
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
10) These experimental findings supported the notion that the so-called telangiectatic focal nodular hyperplasia was in fact a variant of hepatocellular adenoma, rather than typical focal nodular hyperplasia, and should henceforth be designated "telangiectatic adenomas.
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.
of False Neoplastic Site ([dagger]) dagger]) Diagnoses by Pathologists Liver 180 37 Hepatocellular adenoma
, 36 Hepatocellular carcinoma, 21 Benign neoplasm NOS, 5 Metastatic carcinoma NOS, 1 Metastatic small cell carcinoma, 1 Adenocarcinoma (primary or metastatic), 2 Pancreas 171 10 Islet cell or neuroendocrine tumor, 12 Microcystic adenoma, 1 Lympoma, 1 Adenocarcinoma, 1 Carcinoma NOS, 1 Benign neoplasm NOS, 1 Salivary 272 6 Acinic cell carcinoma, 4 gland Squamous cell carcinoma, 2 Monomorphic adenoma, 3 Adenoid cystic carcinoma, 1 Warthin tumor, 1 Benign neoplasm NOS, 5 Kidney 102 60 Renal cell carcinoma, 59 Angiomyolipoma, 1 Metastatic carcinoma NOS, 1 * FNA indicates fine-needle aspiration; NOS, not otherwise specified.
No hepatocellular adenomas or carcinomas were found in the ER juveniles that we examined.
Although two ER juveniles developed altered foci, no hepatocellular adenomas or carcinomas were observed, suggesting that ER larvae are resistant to the carcinogenic effects of BaP.